These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34608996)

  • 1. CASANOVA: Permutation inference in factorial survival designs.
    Ditzhaus M; Genuneit J; Janssen A; Pauly M
    Biometrics; 2023 Mar; 79(1):203-215. PubMed ID: 34608996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferring median survival differences in general factorial designs via permutation tests.
    Ditzhaus M; Dobler D; Pauly M
    Stat Methods Med Res; 2021 Mar; 30(3):875-891. PubMed ID: 33349152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rank-based permutation approaches for non-parametric factorial designs.
    Umlauft M; Konietschke F; Pauly M
    Br J Math Stat Psychol; 2017 Nov; 70(3):368-390. PubMed ID: 28295183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RMST-based multiple contrast tests in general factorial designs.
    Munko M; Ditzhaus M; Dobler D; Genuneit J
    Stat Med; 2024 May; 43(10):1849-1866. PubMed ID: 38402907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of covariance under variance heteroscedasticity in general factorial designs.
    Konietschke F; Cao C; Gunawardana A; Zimmermann G
    Stat Med; 2021 Sep; 40(21):4732-4749. PubMed ID: 34128244
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Gorfine M; Schlesinger M; Hsu L
    Stat Methods Med Res; 2020 Oct; 29(10):2830-2850. PubMed ID: 32183613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric inference in factorial designs with censored data.
    Akritas MG; LaValley MP
    Biometrics; 1996 Sep; 52(3):913-24. PubMed ID: 8805761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
    Royston P; Parmar MK
    BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cox regression can be collapsible and Aalen regression can be non-collapsible.
    Samuelsen SO
    Lifetime Data Anal; 2023 Apr; 29(2):403-419. PubMed ID: 36271175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bootstrap and permutation rank tests for proportional hazards under right censoring.
    Ditzhaus M; Janssen A
    Lifetime Data Anal; 2020 Jul; 26(3):493-517. PubMed ID: 31555996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Checking a semiparametric additive risk model.
    Gandy A; Jensen U
    Lifetime Data Anal; 2005 Dec; 11(4):451-72. PubMed ID: 16328571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A test for comparing current status survival data with crossing hazard functions and its application to immunogenicity of biotherapeutics.
    Jonas SF; Mbogning C; Broët P
    Stat Med; 2017 Nov; 36(27):4364-4377. PubMed ID: 28856703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical inference methods for two crossing survival curves: a comparison of methods.
    Li H; Han D; Hou Y; Chen H; Chen Z
    PLoS One; 2015; 10(1):e0116774. PubMed ID: 25615624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factorial analyses of treatment effects under independent right-censoring.
    Dobler D; Pauly M
    Stat Methods Med Res; 2020 Feb; 29(2):325-343. PubMed ID: 30834811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of factorial survival experiments.
    Slud EV
    Biometrics; 1994 Mar; 50(1):25-38. PubMed ID: 8086609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulating survival data with predefined censoring rates for proportional hazards models.
    Wan F
    Stat Med; 2017 Feb; 36(5):838-854. PubMed ID: 27873333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of covariate effects in Aalen's additive hazard model.
    Lee E; Weissfeld LA
    Stat Med; 1998 May; 17(9):983-98. PubMed ID: 9612886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The wild bootstrap for multivariate Nelson-Aalen estimators.
    Bluhmki T; Dobler D; Beyersmann J; Pauly M
    Lifetime Data Anal; 2019 Jan; 25(1):97-127. PubMed ID: 29512005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.